CONFIDENTIAL TREATMENT REQUESTED BY FLUIDIGM CORPORATION Amendment #1 to the Collaboration and Option Agreement dated May 17, 2010 By and between Fluidigm Corporation and Novartis Vaccines and Diagnostics, Inc.Collaboration and Option Agreement • April 4th, 2011 • Fluidigm Corp • Laboratory analytical instruments
Incorporating the terms and conditions of the Collaboration and Option Agreement made effective May 17, 2010 (hereinafter referred to as the “Agreement”), made by and between Novartis Vaccines and Diagnostics, Inc. (“Novartis”) and Fluidigm Corporation (“Fluidigm”), the Agreement is amended, effective as of March 15, 2011.
BUSINESS FINANCING MODIFICATION AGREEMENTBusiness Financing Modification Agreement • April 4th, 2011 • Fluidigm Corp • Laboratory analytical instruments
This Business Financing Modification Agreement is entered into as of March 31, 2011, by and between Fluidigm Corporation (the “Borrower”) and Bridge Bank, National Association (“Lender”).
